Clinicopathological and molecular characteristics, treatment patterns, and outcomes in patients with KRAS p.G12C-mutated metastatic non-small cell lung cancer (NSCLC) in the AACR Project GENIE database.

被引：0
|
作者：
Ricciuti, Biagio [1 ]
Wang, Chenguang [2 ]
Rizvi, Hira [3 ]
Egger, Jacklynn [1 ]
LeNoue-Newton, Michele [4 ]
Holt, Marilyn [4 ]
Aggarwal, Shivani
Tu, Huakang [5 ]
Hsu, Hil [5 ]
Wang, Xuena [5 ]
Ngarmchamnanrith, Gataree [5 ]
Chia, Victoria [5 ]
Lee, Jocelyn [6 ]
Scharpf, Robert [2 ]
Anagnostou, Valsamo [2 ]
Lovly, Christine [4 ]
Riely, Greg [3 ]
Awad, Mark [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[5] Amgen Inc, Thousand Oaks, CA 91320 USA
[6] Amer Assoc Canc Res, Philadelphia, PA USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
102
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-world clinicopathological and molecular characteristics, treatment patterns, and outcomes in patients with KRAS G12C-mutated metastatic colorectal cancer in AACR Project GENIE.
    Hsu, Hil
    Aggarwal, Shivani
    Balan, Archana
    Ricciuti, Biagio
    Egger, Jacklynn V.
    LeNoue-Newton, Michele
    Holt, Marilyn Elaine
    Lee, Jocelyn
    Chia, Victoria M.
    Chan, Emily
    Rehn, Marko
    Wang, Xuena
    Lovly, Christine M.
    Riely, Gregory J.
    Awad, Mark M.
    Anagnostou, Valsamo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 41 - 41
  • [2] Clinical Characteristics and Outcomes in Patients With KRAS G12C Mutated Non-Small Cell Lung Cancer
    Pellini, B.
    Ganesan, V.
    Wan, F.
    Sankararaman, S.
    Manyanont, S.
    Akhave, N.
    Baggstrom, M.
    Ward, J.
    Waqar, S.
    Morgensztern, D.
    Govindan, R.
    Devarakonda, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S209 - S210
  • [3] Real-World Study of Characteristics and Treatment Outcomes Among Patients with KRAS p.G12C-Mutated or Other KRAS Mutated Metastatic Colorectal Cancer
    Fakih, Marwan
    Tu, Huakang
    Hsu, Hil
    Aggarwal, Shivani
    Chan, Emily
    Rehn, Marko
    Chia, Victoria
    Kopetz, Scott
    ONCOLOGIST, 2022, 27 (08): : 663 - 674
  • [4] The immunotherapy role in patients (pt) with KRAS mutated metastatic non-small cell lung cancer (NSCLC): Differences between KRAS G12C and non-G12C
    Notario Rincon, L.
    Pous, A.
    Lopez-Paradis, A.
    Cerda, G.
    Cucurull, M.
    Hernandez, A.
    Domenech, M.
    Carcereny, E.
    Moran Bueno, M. T.
    Munoz, A.
    Mate, J. L.
    Sanz, C.
    Saigi, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S50 - S50
  • [5] Dissecting the Clinical Characteristics and Treatment Outcomes Correlates of KRAS G12C-Mutated Non-Small Cell Lung Cancer
    Jing, Yawan
    Cheng, Ruixin
    Zeng, Hao
    Huang, Qin
    He, Dongyu
    Sun, Jiayi
    Tian, Panwen
    Li, Yalun
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 : 4507 - 4517
  • [6] Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C-Mutant Non-Small Cell Lung Cancer
    Arbour, Kathryn C.
    Rizvi, Hira
    Plodkowski, Andrew J.
    Hellmann, Matthew D.
    Knezevic, Andrea
    Heller, Glenn
    Yu, Helena A.
    Ladanyi, Marc
    Kris, Mark G.
    Arcila, Maria E.
    Rudin, Charles M.
    Lito, Piro
    Riely, Gregory J.
    CLINICAL CANCER RESEARCH, 2021, 27 (08) : 2209 - 2215
  • [7] Sotorasib in advanced KRAS p.G12C-mutated non-small cell lung cancer (NSCLC): Safety and efficacy data from the global expanded access program (EAP)
    Awad, M.
    Pelizzari, G.
    Stevenson, J. P.
    Majem Tarruella, M.
    Ferreira, C. G. M.
    Petty, W. J.
    Arriola, E.
    de Castro, J.
    Morbeck, I.
    Bauman, J. R.
    Toschi, L.
    Zer, A.
    Metro, G.
    Kalmadi, S.
    Azkarate Martinez, A.
    Xia, C.
    Meloni, A.
    Obiozor, C.
    Maimon, N.
    Novello, S.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1005 - S1005
  • [8] Clinicopathologic characteristics and outcomes for patients with KRAS G12D-mutant non-small cell lung cancer (NSCLC).
    Cooper, Alissa Jamie
    Muzikansky, Alona
    Lennerz, Jochen K.
    Mino-Kenudson, Mari
    Hung, Yin P.
    Piotrowska, Zofia
    Dagogo-Jack, Ibiayi
    Sequist, Lecia V.
    Lin, Jessica Jiyeong
    Gainor, Justin F.
    Heist, Rebecca Suk
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] NRAS mutated non-small cell lung cancer (NSCLC) patients: Characteristics and outcomes
    Dehem, A.
    Mazieres, J.
    Chour, A.
    Guisier, F.
    Ferreira, M.
    Boussageon, M.
    Girard, N.
    Moro-Sibilot, D.
    Cadranel, J.
    Zalcman, G.
    Ricordel, C.
    Wislez, M.
    Munck, C.
    Poulet, C-H.
    Gauvain, C.
    Descarpentries, C.
    Wasielewski, E.
    Cortot, A. B.
    Baldacci, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S1023 - S1024
  • [10] Characteristics and treatment outcomes in advanced stage non-small cell lung cancer patients with KRAS G12C mutation
    Illini, Oliver
    Fabikan, Hannah
    Hochmair, Maximilian J.
    Weinlinger, Christoph
    Krenbek, Dagmar
    Brcic, Luka
    Setinek, Ulrike
    Terbuch, Angelika
    Absenger, Gudrun
    Konji, Selma
    Valipour, Arschang
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (19-20) : 727 - 728
12345